Dr. Rush is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3120 Burnet Ave
Suite 304
Cincinnati, OH 45229Phone+1 513-585-7700Fax+1 513-585-7778
Summary
- Dr. Stephen Rush is a psychiatrist in Cincinnati, OH and is affiliated with University of Cincinnati Medical Center. He received his medical degree from Indiana University School of Medicine and has been in practice 10 years. He specializes in gay, lesbian, and transgender health, neuropsychiatry (including autoimmune encephalitis), and psychopharmacology. He is experienced in the psychiatric manifestations of autoimmune encephalitis, treatment refractory illnesses including bipolar disorder, schizophrenia, depression, and posttraumatic stress disorder as well as psychodynamic psychotherapy. He is also involved in the treatment of refractory depression with transcranial magentic stimulation (TMS) and ketamine. He has served as the medical director of ambulatory services for the Department of Psychiatry at the University of Cincinnati Medical Center since 2019 and is a board member of the CureSz organization.
Education & Training
- University of Cincinnati Medical Center/College of MedicineResidency, Psychiatry, 2009 - 2013
- Indiana University School of MedicineClass of 2009
- Indiana UniversityB.S., Biology, Minor: French, Degree of Distinction for Academic Performance, 1998 - 2003
Certifications & Licensure
- OH State Medical License 2012 - 2026
- American Board of Psychiatry and Neurology Psychiatry
- NeurostarTranscranial magnetic stimulation provider
Awards, Honors, & Recognition
- Top Doctors Cincinnati Magazine, 2021
- Top Provider in Patient Experience University of Cincinnati College of Medicine, 2019
- Medical Student Teaching Award-Inpatient Psychiatry University of Cincinnati Department of Psychiatry and Behavioral Neuroscience, 2017
- Join now to see all
Clinical Trials
- A Study to Compare Disease Progression and Modification Following Treatment With Paliperidone Palmitate Long-Acting Injection or Oral Antipsychotics in Participant's With Recent-onset Schizophrenia or Schizophreniform Start of enrollment: 2015 Jul 08
- Comparative Effectiveness Research Trial for Antidepressant Incomplete and Non-responders With TRD Start of enrollment: 2017 May 01
Publications & Presentations
PubMed
- 32 citationsc-jun amino-terminal kinase and mitogen activated protein kinase 1/2 mediate hepatocyte growth factor-induced migration of brain endothelial cells.Stephen Rush, Gausal A. Khan, Ayoola Bamisaiye, Philip Bidwell, H. Anne Leaver
Experimental Cell Research. 2007-01-01
Journal Articles
Abstracts/Posters
- Neurotoxic Effects of the Older Antipsychotics: Several Molecular Mechanisms of Action.Rush, S and Nasrallah, N., Annual meeting of the American Psychiatric Association, San Francisco, CA., 5/1/2013
- Constitutive expression of the microsomal prostaglandin E synthase regulates glioma cell growth via the production of prostaglandin E2Rizzo MT, Knapp B and Rush S, Prostaglandins and Other Lipid Mediators, 3/2006
- Neurotoxic Effects of the Older Antipsychotics: Several Molecular Mechanisms of ActionRush, SJ and Nasrallah, NA, American Psychiatric Association, San Francisco, CA
Lectures
- Crossroads: Autoimmune Encephalitis and PsychiatryEuroimmun Neuroimmunology Summit - 6/15/2020
- Secondary Psychosis: Differential Diagnosis of a First EpisodeCollege of Psychiatric and Neurologic Pharmacists Annual Meeting - 4/15/2020
- Autoimmune Encephalitis: The Crossroads of Neurology and PsychiatryUniversity of Cincinnati Medical Center/Autoimmune Encephalitis Alliance - 8/17/2019
- Join now to see all
Authored Content
- Constitutive expression of the microsomal prostaglandin E synthase regulates glioma cell growth via the production of prostaglandin E2January 2007
Press Mentions
- Catatonic Schizophrenia: How to Recognize the Symptoms of a Catatonic StateJuly 17th, 2019
- Computer-Assisted Cognitive Remediation for SchizophreniaMay 13th, 2019
- Magnetic Force: How TMS Therapy for Depression Got Patient Back on StageJune 7th, 2018
- Join now to see all
Research History
- Sub-investigator“A Study to Compare Disease Progression and Modification Following Treatment with Paliperidone Palmitate Long-Acting Injection or Oral Antipsychotics in Participant's With Recent-onset Schizophrenia or Schizophreniform (DREaM).” Janssen Pharmaceuticals. UC Department of Psychiatry2015 - 2018
Professional Memberships
- Member
- Clinical TMS SocietyMember
- OPPAMember
- Schizophrenia International Research SocietyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: